Abstract:figure legend This study examined the effect of lactate on the rate‐limiting enzymes in amyloid precursor protein processing. The results demonstrate that lactate increases ADAM10 activity and reduces BACE1 activity. These findings suggest that lactate is important for regulating amyloid precursor protein (APP) processing. The accumulation and aggregation of beta‐amyloid (Aβ) peptides contributes to neuronal dysfunction and death. These Aβ peptides originate from a transmembrane protein known as amyloid precursor protein (APP), which can be processed via two competing pathways. Alpha‐secretase (ADAM10) cleavage is thought to be neuroprotective while beta‐secretase (BACE1) cleavage results in the production of Aβ. Aerobic exercise reduces BACE1 activity, but the mechanisms involved are unknown though several exercise‐induced mediators such as lactate may be involved. The current study examined whether systemic lactate can alter APP processing and BACE1 and ADAM10 activity. Mice were randomly assigned to one of four groups (n = 10 per group): (1) sedentary; (2) lactate‐injection (1.0 g kg−1 body mass); (3) exercise; and (4) exercise and oxamate (lactate dehydrogenase inhibitor; 750 mg kg−1 body mass). Two hours following intervention, the hippocampus and prefrontal cortex (PFC) were collected. In the PFC lactate‐injection and exercise resulted in higher ADAM10 activity compared to sedentary (exercise P = 0.0215, lactate P = 0.0038), in the hippocampus lactate‐injection was higher compared to sedentary (lactate P = 0.011), and this was absent in the presence of oxamate. Hippocampal BACE1 activity was lower in the lactate group compared to the exercise group (P = 0.01). Oxamate resulted in higher BACE1 protein content compared to sedentary in the PFC (vs. sedentary P = 0.048). These findings suggest that lactate is important for regulating ADAM10 activity and thereby shifts APP processing away from Aβ production. Key points Exercise is known to alter the processing of amyloid precursor protein by reducing the activity of the rate‐limiting enzyme BACE1 and increasing the activity of ADAM10. It is thought that exercise‐induced factors are responsible for these enzymatic changes. This study examined if lactate accumulation plays a role in this process. Mice were assigned to one of four groups: sedentary, lactate, exercise and exercise + lactate. The findings demonstrate that lactate accumulation alters brain BACE1 and ADAM10 and shifts amyloid precursor protein processing away from beta‐amyloid production.

Reduction of cerebral lactate level in 3-month-old APP/PS1 mouse: The relationship with Aβ production

Inhibition of Lactate-GPR81-PI3K/Akt Pathway May Exacerbate Aβ Aggregation in 3-Month-Old APP/PS1 Mice

A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model.

Lactate Deficit in an Alzheimer Disease Mouse Model: The Relationship With Neuronal Damage

Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.

Immunoproteasome Subunit Low Molecular Mass Peptide 2 (LMP2) Deficiency Ameliorates LPS/Aβ1-42-Induced Neuroinflammation

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).

Astrocyte-derived Lactoferrin Reduces Β-Amyloid Burden by Promoting the Interaction Between P38 Kinase and PP2A Phosphatase in Male APP/PS1 Transgenic Mice

Lactate increases ADAM10 activity and reduces BACE1 activity in mouse brain

Astrocyte-derived lactoferrin reduces Aβ burden by promoting the interaction of p38 and PP2A in APP/PS1 transgenic mice

Astrocyte‐derived lactoferrin reduces Aβ burden by promoting the interaction of p38 and PP2A in male APP/PS1 transgenic mice

Soluble Β-Amyloid Impaired the GABA Inhibition by Mediating KCC2 in Early APP/PS1 Mice.

A fragment of cell adhesion molecule L1 reduces amyloid-β plaques in a mouse model of Alzheimer’s disease

Reversible GABAergic dysfunction involved in hippocampal hyperactivity predicts early-stage Alzheimer disease in a mouse model

APPswe /PS1ΔE9 mice exhibit low oxygen saturation and alterations of erythrocytes preceding the neuropathology and cognitive deficiency during Alzheimer's disease

Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice.

Multiple Inflammatory Profiles of Microglia and Altered Neuroimages in APP/PS1 Transgenic AD Mice.

Altered brain arginine metabolism with age in the APPswe/PSEN1dE9 mouse model of Alzheimer's disease

Early Disruption of Synaptic Function, Impairment of Plasticity, and Decreased of Cortical Circuit Connectivity in an Alzheimer’S Mouse Model of Amyloid Deposition

Dynamic Changes in the Levels of Amyloid-β42 Species in the Brain and Periphery of APP/PS1 Mice and Their Significance for Alzheimer’s Disease

Early-stage Reduction of the Dendritic Complexity in Basolateral Amygdala of a Transgenic Mouse Model of Alzheimer's Disease